A Phase 3 Study of HS-20094 in Patients With T2DM

Clinical trial NCT07156539 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07156539
Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Type 2 Diabetes

Start date: 2025-09-30
Primary completion: 2027-03-30
Enrollment: 546

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.